Loading...
Mar 21, 2023 - Sep 20, 2023

Natco Pharma Limited Buyback (Natco Pharma Buyback 2023) Detail

Incorporated in 1981, Natco Pharma Limited is a vertically integrated and R&D-focused pharmaceutical company. the entity is engaged in developing, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).

Natco Pharma primarily focuses on niche therapeutic areas and complex products. They market and distribute their products in more than 40 countries. Some of the countries where Natco sells its FDF products are the United States, India, and Europe.

Alongside working through direct operations, the company also operates in certain key geographies through its subsidiaries.

Natco Pharma Buyback 2023 Detail

Issue PeriodMar 21, 2023 - Sep 20, 2023
Security NameNatco Pharma Limited
Issue TypeOpen Market Through Stock Exchange
Issue Size (Amount)₹210.00 Crores
Buyback Price₹700 per share
Face Value₹2 per share
Listing AtBSE, NSE

Company Financials

Natco Pharma Limited Financial Information (Restated Consolidated)
Period EndedTotal RevenueProfit After TaxNet Worth
31-Mar-202,022.40458.103,773.50
31-Mar-212,155.70442.404,121.60
31-Mar-222,043.80170.004,263.60
31-Dec-221,884.80439.504,628.20
Amount in ₹ Crore

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 554.95 502.00 535.04
Jan-2023 570.40 526.00 545.28
Dec-2022 599.00 548.00 565.78

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 555.00 502.00 534.88
Jan-2023 570.00 526.10 545.36
Dec-2022 600.00 547.50 565.78

Necessity of the Issue

The Buyback is being undertaken for the following reasons:

  1. The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares
  2. The Buyback may help in improving return on equity, by the reduction in the equity base.
  3. The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer.

Natco Pharma Buyback 2023 Documents

Natco Pharma Buyback 2023 Rating

0
0.0
Rating:Rated 0.0 stars
Vote Here ...

Natco Pharma Buyback 2023 Reviews

Sorry, we couldn't find any reviews, please check back later.

Company Contact Information

Natco Pharma Limited
Natco House Road No.2,
Banjara Hills
Hyderabad-500 034

Phone: +91-40-2354 7532
Email: investors@natcopharma.co.in
Website: https://www.natcopharma.co.in/

Natco Pharma Buyback 2023 Registrar

  1. Venture Capital And Corporate Investments Pvt Ltd
       12-10-167,
       Bharat Nagar,
       Hyderabad, 500018

    Phone: 040-23818475, 23818476, 23868023
    Email: pvsrinivas@vccipl.com
    Website: https://www.vccipl.com

Natco Pharma Buyback 2023 Manager

Lead Manager(s)

  1. DAM Capital Advisors Ltd (Formerly IDFC Securities Ltd)

Registered Broker

  1. DAM Capital Advisors Limited
    Email: rajesh@damcapital.in

Find Natco Pharma Buyback 2023 Latest Update

Natco Pharma Buyback 2023 FAQs

The Natco Pharma Buyback 2023 opens on Mar 21, 2023, and closes on Sep 20, 2023.

The Natco Pharma Buyback 2023 is a Open Market Through Stock Exchange.

Natco Pharma Buyback 2023 Schedule

Buyback Opening DateMar 21, 2023
Buyback Closing DateSep 20, 2023
Last date for acceptance of sharesUpon relevant pay-out by the Stock exchange

The Natco Pharma Buyback 2023 is being offered at Rs ₹700 per share per equity share.

There is no ratio applicable in case of open market offer through stock exchange mechanism.

There is no concept of record date in case of open market through stock exchange mechanism.

The Natco Pharma Buyback 2023 has announced a buyback for an aggregate amount of not more than Rs. ₹210.00 Crores with pricing of Rs.₹700 per share.

The Buyback is being undertaken for the following reasons:

  1. The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares
  2. The Buyback may help in improving return on equity, by the reduction in the equity base.
  3. The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer.

Any equity shareholder holding the shares in Demat form can participate in the buyback offer through their stockbroker. The physical shareholder can participate only once the shares get converted into a Dematerialized form.

The shareholder needs to inform their broker on the details of the Equity shares they wish to sell. The broker will place a sell order whenever the company places a buy order for the buyback. The trade would get executed at the offer price or lesser only when the price offered by the shareholder matches with the buy order placed by the company.

The Natco Pharma Buyback 2023 offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one's need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.


Comments

Add a public comment...